These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 2957608)
1. EEG assessment of the sedative and excitatory properties of CNS-active compounds in the patients with depression. Matousek M Neuropsychobiology; 1987; 17(1-2):118-20. PubMed ID: 2957608 [TBL] [Abstract][Full Text] [Related]
2. Double-blind comparison between a serotonin and a noradrenaline reuptake blocker in the treatment of depressed outpatients. Clinical aspects. Nyström C; Hällström T Acta Psychiatr Scand; 1985 Jul; 72(1):6-15. PubMed ID: 2930998 [TBL] [Abstract][Full Text] [Related]
3. Are there distinct biochemical subtypes of depression? EEG characteristics of clinically defined on-drug responders and non-responders. Ulrich G; Haug HJ; Stieglitz RD; Fähndrich E J Affect Disord; 1988; 15(2):181-5. PubMed ID: 2975689 [TBL] [Abstract][Full Text] [Related]
4. [Analysis of the efficacy of EEG after maprotiline administration]. Libiger J; Hanus H; Kindernayová H; Valach M; Zapletálek M Act Nerv Super (Praha); 1982 May; 24(2):106-11. PubMed ID: 7102222 [No Abstract] [Full Text] [Related]
5. The use of the EEG for assessment of vigilance changes caused by beta-blockers. Matousek M; Hjalmarson A; Koch J; Petersén I Neuropsychobiology; 1984; 12(1):55-9. PubMed ID: 6514178 [TBL] [Abstract][Full Text] [Related]
6. Maprotiline hydrochloride associated with a clinical state of catatonic stupor and epileptic encephalogram. Atri PB; Julius DA J Clin Psychopharmacol; 1984 Aug; 4(4):207-9. PubMed ID: 6470193 [TBL] [Abstract][Full Text] [Related]
7. [Maprotiline and its undesired effects]. Tesarová O Act Nerv Super (Praha); 1982 May; 24(2):90-2. PubMed ID: 7048836 [No Abstract] [Full Text] [Related]
8. Grand mal seizures induced by maprotiline. Holliday W; Brasfield KH; Powers B Am J Psychiatry; 1982 May; 139(5):673-4. PubMed ID: 6803598 [No Abstract] [Full Text] [Related]
16. Case report of hepatotoxicity associated with maprotiline. Weinstein RP; Gosselin JY Can J Psychiatry; 1988 Apr; 33(3):233-4. PubMed ID: 3383098 [TBL] [Abstract][Full Text] [Related]
17. Plasma levels of maprotiline and zimelidine and their relationship to clinical response in depressed patients. Hrdina PD; Lapierre YD Ther Drug Monit; 1986; 8(4):400-6. PubMed ID: 2950616 [TBL] [Abstract][Full Text] [Related]
18. Comparison between a serotonin and a noradrenaline reuptake blocker in the treatment of depressed outpatients. Biochemical aspects. Nyström C; Ross SB; Hällström T; Kelder D Acta Psychiatr Scand; 1986 Feb; 73(2):133-8. PubMed ID: 2939691 [TBL] [Abstract][Full Text] [Related]
19. Maprotiline. Grüter W; Pöldinger W Mod Probl Pharmacopsychiatry; 1982; 18():17-48. PubMed ID: 7048074 [No Abstract] [Full Text] [Related]
20. [Biochemical, pharmacologic and psychophysiologic studies for the optimization of drug therapy in depressive illnesses]. Gaertner HJ; Giedke H; Breyer-Pfaff U Nervenarzt; 1984 Mar; 55(3):133-6. PubMed ID: 6717696 [No Abstract] [Full Text] [Related] [Next] [New Search]